Medicare Enrolled
Dr. Yuvraj Heir, M.D.
Neurology · The Woodlands, TX
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Heir from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Heir?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Heir
Dr. Yuvraj Heir is a neurology specialist in The Woodlands, TX, with 12 years of NPI registration. Based on federal Medicare data, Dr. Heir performed 1,335 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. Heir received a total of $17,215 from 78 pharmaceutical and/or device companies across 937 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Heir is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 12 years of NPI registration
▲ Top 25% volume in TX
$17,215 industry payments
Medicare Practice Summary — 2023
Medicare Utilization ↗1,335
Medicare services
Top 25% in TX for neurology
Not available
Unique patients (not deduplicated)
$111
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
350 | $91 | $236 |
| Electromyography of arm or leg muscles A test that measures the electrical activity in the muscles of the arm or leg using a needle electrode. It helps evaluate the health of muscles and the nerve cells that control them. |
335 | $74 | $300 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
232 | $116 | $362 |
| Nerve conduction studies, 11-12 A diagnostic test that measures how well nerves send electrical signals. It involves performing 11 to 12 separate nerve conduction studies. |
88 | $184 | $787 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
82 | $63 | $159 |
| Nerve conduction study, 9-10 studies A diagnostic test that measures how well nerves send electrical signals. It involves performing 9 to 10 separate nerve conduction studies to evaluate nerve function. |
79 | $150 | $670 |
| EEG brain wave monitoring, 41-60 minutes This procedure involves monitoring and recording electrical activity in the brain using electrodes placed on the scalp for a duration of 41 to 60 minutes. |
73 | $255 | $655 |
| New patient office visit, complex (60-74 min) | 57 | $132 | $450 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
39 | $124 | $316 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
Industry Payment Transparency
Open Payments through 2024 ↗$17,215
Total received (2019-2024)
Avg $2,869/year across 6 years
Top 19% in TX for neurology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
78
Companies
937
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$4,265
2023
$3,751
2022
$3,559
2021
$2,938
2020
$1,904
2019
$798
Payments by company (2024)
UCB, Inc.
$621
ABBVIE INC.
$395
Alexion Pharmaceuticals, Inc.
$253
Lilly USA, LLC
$253
Amgen Inc.
$246
PFIZER INC.
$231
EMD Serono, Inc.
$228
Novartis Pharmaceuticals Corporation
$228
Takeda Pharmaceuticals U.S.A., Inc.
$228
Teva Pharmaceuticals USA, Inc.
$225
AstraZeneca Pharmaceuticals LP
$212
Neurocrine Biosciences, Inc.
$155
Abbott Laboratories
$153
Eisai Inc.
$145
Biogen, Inc.
$124
SK Life Science, Inc.
$100
Boston Scientific Corporation
$89
Otsuka America Pharmaceutical, Inc.
$83
Collegium Pharmaceutical, Inc.
$41
Neurelis, Inc.
$37
Averitas Pharma Inc.
$35
Lundbeck LLC
$29
ACADIA Pharmaceuticals Inc
$25
Azurity Pharmaceuticals, Inc.
$23
LivaNova USA, Inc.
$23
ARGENX US, INC.
$23
Nevro Corp.
$17
Medtronic, Inc.
$17
Celgene Corporation
$17
InSightec,Inc
$6
Aucta Pharmaceuticals, Inc.
$4
Top 3 companies account for 29.8% of 2024 payments
All-time payments by company (2019-2024) ›
UCB, Inc.
$1,792
ABBVIE INC.
$1,105
Amgen Inc.
$943
EMD Serono, Inc.
$918
Novartis Pharmaceuticals Corporation
$829
Teva Pharmaceuticals USA, Inc.
$715
GENZYME CORPORATION
$644
SK Life Science, Inc.
$599
Biogen, Inc.
$581
Allergan, Inc.
$565
Lilly USA, LLC
$527
AstraZeneca Pharmaceuticals LP
$514
Eisai Inc.
$508
ACADIA Pharmaceuticals Inc
$497
AbbVie Inc.
$415
PFIZER INC.
$413
Biohaven Pharmaceutical Holding Company Ltd.
$385
Abbott Laboratories
$370
Alexion Pharmaceuticals, Inc.
$321
Lundbeck LLC
$320
Takeda Pharmaceuticals U.S.A., Inc.
$320
Neurocrine Biosciences, Inc.
$307
Amneal Pharmaceuticals LLC
$280
Biohaven Pharmaceuticals, Inc.
$197
Janssen Pharmaceuticals, Inc
$178
Avanir Pharmaceuticals, Inc.
$175
Grifols USA, LLC
$164
Celgene Corporation
$156
Acorda Therapeutics, Inc
$153
Supernus Pharmaceuticals, Inc.
$139
EISAI INC.
$131
Otsuka America Pharmaceutical, Inc.
$130
MDD US Operations, LLC
$121
Boston Scientific Corporation
$119
ARGENX US, INC.
$118
JAZZ PHARMACEUTICALS INC.
$104
Neurelis, Inc.
$97
Averitas Pharma Inc.
$95
Akcea Therapeutics, Inc.
$92
CSL Behring
$92
MITSUBISHI TANABE PHARMA AMERICA, INC.
$88
Sumitomo Pharma America, Inc.
$67
UPSHER-SMITH LABORATORIES LLC
$66
Kyowa Kirin, Inc.
$63
Piramal Critical Care
$43
Collegium Pharmaceutical, Inc.
$41
ASSERTIO THERAPEUTICS, Inc.
$40
Zyla Life Sciences
$40
GE HEALTHCARE
$37
Corium, LLC
$37
Allergan Inc.
$36
Sarepta Therapeutics, Inc.
$36
Medtronic, Inc.
$36
CATALYST PHARMACEUTICALS, INC.
$29
Alnylam Pharmaceuticals Inc.
$28
Saluda Medical Americas, Inc.
$27
Merz Pharmaceuticals, LLC
$27
ARBOR PHARMACEUTICALS, INC.
$26
ZOLL Respicardia, Inc.
$26
Azurity Pharmaceuticals, Inc.
$23
LivaNova USA, Inc.
$23
Jazz Pharmaceuticals Inc.
$22
Curonix LLC
$19
Microtransponder, Inc.
$17
Nevro Corp.
$17
Mitsubishi Tanabe Pharma America, Inc.
$17
Greenwich Biosciences, Inc.
$17
PIRAMAL CRITICAL CARE
$17
GRT US Holding, Inc.
$16
GE HealthCare
$15
Vertical Pharmaceuticals, LLC
$14
Assertio Therapeutics, Inc.
$14
Currax Pharmaceuticals LLC
$14
US WorldMeds, LLC
$13
Genentech USA, Inc.
$13
IMPEL PHARMACEUTICALS INC.
$12
InSightec,Inc
$6
Aucta Pharmaceuticals, Inc.
$4
Top 3 companies account for 22.3% of all-time payments
Associated products mentioned in payments ›
ACTIVA PC · ADLARITY · ADUHELM · AFINITOR · AIMOVIG · AJOVY · AMYVID · ANDEXXA · APOKYN · APTIOM · AUBAGIO · AUSTEDO · AVONEX · Adlarity · Aimovig · Austedo XR · BOTOX · Briviact · CAMBIA · COMIRNATY · CONTRAVE · Cambia · DIVIGEL · DUOPA · Dayvigo · EMGALITY · EPIDIOLEX · Epidiolex · Evoke SCS · Exablate · Exondys 51 · FIRDAPSE · Fintepla · Fycompa · GABLOFEN · GAMMAGARD · Gamunex-C · HORIZANT · HYQVIA · Hizentra · Horizant · INBRIJA · INFINITY · INGREZZA · KESIMPTA · LINZESS · Leqembi · MAVENCLAD · MYOBLOC · Mavenclad · Motpoly XR · NEXVIAZYME · NORTHERA · NOURIANZ · NUEDEXTA · NUPLAZID · NURTEC ODT · Nayzilam · Nourianz · Nucynta · Nuedexta · ONPATTRO · OXTELLAR XR · Ocrevus · Ongentys · PANZYGA · PNS FREEDOM-4A PERMANENT NEUROSTIMULATOR RECEIVER KIT CHANNEL A · POMPE - DISEASE · Ponvory · QULIPTA · QUTENZA · Qutenza · RADICAVA · REXULTI · RYTARY · Radicava · Rystiggo · SOLIRIS · SPINRAZA · SPRIX · SUNOSI · Senza · TEGSEDI · TOSYMRA · TROKENDI XR · TYSABRI · Trudhesa · UBRELVY · ULTOMIRIS · UPLIZNA · VALTOCO · VNS THERAPY SENTIVA MODEL 1000 GENERATOR · VUMERITY · VYEPTI · VYVGART · VYVGART HYTRULO · Vercise · Vimpat · XADAGO · XCOPRI · XTAMPZA · Xadago · Xembify · Xeomin · ZEMBRACE SYMTOUCH · ZEPOSIA · remede System
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Neurologists in nearby ZIP areas
68
County median income
$97,266
Nearest hospital to ZIP centroid (approximate)
HOUSTON METHODIST THE WOODLANDS HOSPITAL
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Heir is a clinical cardiology specialist, with above-average Medicare volume (top 25% in TX).
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Heir experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Heir performed 350 office visit, established patient (30-39 min) services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Heir receive payments from pharmaceutical companies?
Yes. Dr. Heir received a total of $17,215 from 78 companies across 937 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Heir's costs compare to other neurologists in The Woodlands?
Dr. Heir's average Medicare payment per service is $111. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Heir) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Specialty guide
Understanding Neurology
Common procedures, typical costs, and what industry payments mean in neurology.
Same specialty & city
Neurologists in The Woodlands
Browse neurologists in The Woodlands ranked by procedure volume and transparency data.
Highest volume
Top Neurologists in TX
Neurologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Neurologists in TX
Which TX neurologists receive the most from drug and device companies.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology